US Stock MarketDetailed Quotes

CRSP CRISPR Therapeutics

Watchlist
  • 69.100
  • -1.060-1.51%
Trading Mar 28 10:40 ET
5.76BMarket Cap-35618P/E (TTM)

CRISPR Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
84,762.39%370M
3,333,233.33%200M
0
44,203.80%70M
56,079.78%100M
-99.95%436K
-99.95%6K
-71.43%94K
-99.98%158K
-11.88%178K
Operating revenue
84,762.39%370M
3,333,233.33%200M
--0
44,203.80%70M
56,079.78%100M
-99.95%436K
-99.95%6K
-71.43%94K
-99.98%158K
-11.88%178K
Cost of revenue
18.14%130.25M
193.13%20M
-39.73%23.42M
31.58%44.64M
37.68%42.19M
8.97%110.25M
-78.56%6.82M
72.98%38.86M
25.89%33.92M
53.65%30.65M
Gross profit
318.32%239.75M
2,740.46%180M
39.58%-23.42M
175.12%25.36M
289.73%57.81M
-113.53%-109.81M
65.00%-6.82M
-75.13%-38.77M
-103.87%-33.76M
-54.32%-30.47M
Operating expense
-17.94%462.29M
-11.47%110.42M
-24.11%108.99M
-19.34%120.59M
-15.95%122.3M
28.51%563.35M
-1.19%124.72M
34.59%143.62M
35.12%149.5M
53.49%145.5M
Selling and administrative expenses
-25.67%76.16M
-22.16%16.48M
-32.26%18.29M
-27.56%19.03M
-20.20%22.36M
2.78%102.46M
-10.60%21.17M
13.89%27M
-8.79%26.27M
14.29%28.02M
-General and administrative expense
-25.67%76.16M
-22.16%16.48M
-32.26%18.29M
-27.56%19.03M
-20.20%22.36M
2.78%102.46M
-10.60%21.17M
13.89%27M
-8.79%26.27M
14.29%28.02M
Research and development costs
-16.10%387.33M
-8.12%95.14M
-22.23%90.7M
-17.58%101.56M
-15.48%99.94M
35.55%461.65M
0.45%103.56M
39.67%116.62M
49.67%123.22M
67.44%118.25M
Other operating expenses
-58.27%-1.21M
----
----
----
----
59.51%-762K
--0
----
----
-126.11%-762K
Operating profit
66.94%-222.54M
152.90%69.58M
27.40%-132.41M
48.04%-95.22M
63.35%-64.49M
-280.22%-673.16M
9.72%-131.54M
-41.55%-182.39M
-124.03%-183.26M
-53.63%-175.97M
Net non-operating interest income expense
Other net income (expense)
216.91%71.82M
74.04%20M
184.57%20.67M
419.36%18.41M
3,410.19%12.74M
277.49%22.66M
422.99%11.49M
559.76%7.26M
372.53%3.54M
-81.43%363K
Other non- operating income (expenses)
216.91%71.82M
74.04%20M
184.57%20.67M
419.36%18.41M
3,410.19%12.74M
277.49%22.66M
422.99%11.49M
559.76%7.26M
372.53%3.54M
-81.43%363K
Income before tax
76.83%-150.72M
174.62%89.58M
36.19%-111.74M
57.26%-76.82M
70.53%-51.75M
-271.40%-650.5M
16.34%-120.05M
-37.09%-175.12M
-123.54%-179.72M
-55.97%-175.61M
Income tax
988.62%2.89M
102.46%233K
171.65%412K
-84.91%923K
-63.41%1.32M
-117.38%-325K
-320.59%-9.48M
3.36%-575K
47.67%6.12M
527.48%3.61M
Net income
76.37%-153.61M
180.80%89.35M
35.75%-112.15M
58.17%-77.74M
70.39%-53.07M
-272.16%-650.18M
21.72%-110.58M
-37.27%-174.55M
-124.48%-185.83M
-58.37%-179.22M
Net income continuous Operations
76.37%-153.61M
180.80%89.35M
35.75%-112.15M
58.17%-77.74M
70.39%-53.07M
-272.16%-650.18M
21.72%-110.58M
-37.27%-174.55M
-124.48%-185.83M
-58.37%-179.22M
Minority interest income
Net income attributable to the parent company
76.37%-153.61M
180.80%89.35M
35.75%-112.15M
58.17%-77.74M
70.39%-53.07M
-272.16%-650.18M
21.72%-110.58M
-37.27%-174.55M
-124.48%-185.83M
-58.37%-179.22M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
76.37%-153.61M
180.80%89.35M
35.75%-112.15M
58.17%-77.74M
70.39%-53.07M
-272.16%-650.18M
21.72%-110.58M
-37.27%-174.55M
-124.48%-185.83M
-58.37%-179.22M
Basic earnings per share
76.79%-1.94
180.14%1.13
37.05%-1.41
59.17%-0.98
71.12%-0.67
-268.21%-8.36
23.37%-1.41
-34.13%-2.24
-123.98%-2.4
-53.64%-2.32
Diluted earnings per share
76.79%-1.94
180.14%1.13
37.05%-1.41
59.17%-0.98
71.12%-0.67
-277.87%-8.36
23.37%-1.41
-34.13%-2.24
-125.42%-2.4
-53.64%-2.32
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 84,762.39%370M3,333,233.33%200M044,203.80%70M56,079.78%100M-99.95%436K-99.95%6K-71.43%94K-99.98%158K-11.88%178K
Operating revenue 84,762.39%370M3,333,233.33%200M--044,203.80%70M56,079.78%100M-99.95%436K-99.95%6K-71.43%94K-99.98%158K-11.88%178K
Cost of revenue 18.14%130.25M193.13%20M-39.73%23.42M31.58%44.64M37.68%42.19M8.97%110.25M-78.56%6.82M72.98%38.86M25.89%33.92M53.65%30.65M
Gross profit 318.32%239.75M2,740.46%180M39.58%-23.42M175.12%25.36M289.73%57.81M-113.53%-109.81M65.00%-6.82M-75.13%-38.77M-103.87%-33.76M-54.32%-30.47M
Operating expense -17.94%462.29M-11.47%110.42M-24.11%108.99M-19.34%120.59M-15.95%122.3M28.51%563.35M-1.19%124.72M34.59%143.62M35.12%149.5M53.49%145.5M
Selling and administrative expenses -25.67%76.16M-22.16%16.48M-32.26%18.29M-27.56%19.03M-20.20%22.36M2.78%102.46M-10.60%21.17M13.89%27M-8.79%26.27M14.29%28.02M
-General and administrative expense -25.67%76.16M-22.16%16.48M-32.26%18.29M-27.56%19.03M-20.20%22.36M2.78%102.46M-10.60%21.17M13.89%27M-8.79%26.27M14.29%28.02M
Research and development costs -16.10%387.33M-8.12%95.14M-22.23%90.7M-17.58%101.56M-15.48%99.94M35.55%461.65M0.45%103.56M39.67%116.62M49.67%123.22M67.44%118.25M
Other operating expenses -58.27%-1.21M----------------59.51%-762K--0---------126.11%-762K
Operating profit 66.94%-222.54M152.90%69.58M27.40%-132.41M48.04%-95.22M63.35%-64.49M-280.22%-673.16M9.72%-131.54M-41.55%-182.39M-124.03%-183.26M-53.63%-175.97M
Net non-operating interest income expense
Other net income (expense) 216.91%71.82M74.04%20M184.57%20.67M419.36%18.41M3,410.19%12.74M277.49%22.66M422.99%11.49M559.76%7.26M372.53%3.54M-81.43%363K
Other non- operating income (expenses) 216.91%71.82M74.04%20M184.57%20.67M419.36%18.41M3,410.19%12.74M277.49%22.66M422.99%11.49M559.76%7.26M372.53%3.54M-81.43%363K
Income before tax 76.83%-150.72M174.62%89.58M36.19%-111.74M57.26%-76.82M70.53%-51.75M-271.40%-650.5M16.34%-120.05M-37.09%-175.12M-123.54%-179.72M-55.97%-175.61M
Income tax 988.62%2.89M102.46%233K171.65%412K-84.91%923K-63.41%1.32M-117.38%-325K-320.59%-9.48M3.36%-575K47.67%6.12M527.48%3.61M
Net income 76.37%-153.61M180.80%89.35M35.75%-112.15M58.17%-77.74M70.39%-53.07M-272.16%-650.18M21.72%-110.58M-37.27%-174.55M-124.48%-185.83M-58.37%-179.22M
Net income continuous Operations 76.37%-153.61M180.80%89.35M35.75%-112.15M58.17%-77.74M70.39%-53.07M-272.16%-650.18M21.72%-110.58M-37.27%-174.55M-124.48%-185.83M-58.37%-179.22M
Minority interest income
Net income attributable to the parent company 76.37%-153.61M180.80%89.35M35.75%-112.15M58.17%-77.74M70.39%-53.07M-272.16%-650.18M21.72%-110.58M-37.27%-174.55M-124.48%-185.83M-58.37%-179.22M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 76.37%-153.61M180.80%89.35M35.75%-112.15M58.17%-77.74M70.39%-53.07M-272.16%-650.18M21.72%-110.58M-37.27%-174.55M-124.48%-185.83M-58.37%-179.22M
Basic earnings per share 76.79%-1.94180.14%1.1337.05%-1.4159.17%-0.9871.12%-0.67-268.21%-8.3623.37%-1.41-34.13%-2.24-123.98%-2.4-53.64%-2.32
Diluted earnings per share 76.79%-1.94180.14%1.1337.05%-1.4159.17%-0.9871.12%-0.67-277.87%-8.3623.37%-1.41-34.13%-2.24-125.42%-2.4-53.64%-2.32
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg